Hope for ataxia: new pill aims to slow worsening of balance and speech
NCT ID NCT03701399
First seen Nov 05, 2025 · Last updated May 24, 2026 · Updated 23 times
Summary
This study tests whether a daily pill called troriluzole can help adults with spinocerebellar ataxia, a rare brain disease that affects balance, walking, and speech. About 300 participants took either the drug or a placebo for 48 weeks. The main goal was to see if the drug slows down worsening of movement problems. This is a late-stage trial, but the drug is not a cure—it aims to control symptoms and slow disease progression.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SPINOCEREBELLAR ATAXIA TYPE 6 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Barrow Neurological Institute
Phoenix, Arizona, 85013, United States
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02215, United States
-
CNS Trials
Long Beach, California, 90806, United States
-
Central South University Xiangya Hospital
Changsha, Hunan, 410008, China
-
Columbia University
New York, New York, 10032, United States
-
Duke University Movement Disorders Clinic
Durham, North Carolina, 27705, United States
-
Emory
Atlanta, Georgia, 30329, United States
-
Houston Methodist
Houston, Texas, 77030, United States
-
Johns Hopkins Medicine
Lutherville, Maryland, 21093, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Mayo Clinic Florida
Jacksonville, Florida, 32224, United States
-
Northwest Neurology, Ltd.
Rolling Meadows, Illinois, 60008, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
Swedish Health Services
Seattle, Washington, 98122, United States
-
UCLA
Los Angeles, California, 90095, United States
-
UCSF
San Francisco, California, 94158, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Colorado Hospital
Aurora, Colorado, 80045, United States
-
University of Florida Health
Gainesville, Florida, 32610, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19107, United States
-
University of South Florida
Tampa, Florida, 33612, United States
-
West China Hospital of Sichuan University
Chengdu, Sichuan, 610041, China
Conditions
Explore the condition pages connected to this study.